BI Asset Management Fondsmaeglerselskab A S raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 175.5% in the 4th quarter, Holdings Channel reports. The firm owned 16,526 shares of the biotechnology company’s stock after purchasing an additional 10,527 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Axon Enterprise were worth $9,822,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently bought and sold shares of the company. Capital World Investors increased its position in Axon Enterprise by 86.4% in the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock worth $1,079,145,000 after buying an additional 841,772 shares during the period. Alliancebernstein L.P. increased its holdings in shares of Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after acquiring an additional 812,337 shares during the period. Norges Bank bought a new stake in Axon Enterprise in the 4th quarter valued at about $482,081,000. GQG Partners LLC acquired a new position in Axon Enterprise during the 4th quarter valued at about $478,349,000. Finally, Vanguard Group Inc. increased its stake in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the period. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Trading Down 2.2 %
Shares of NASDAQ:AXON opened at $559.53 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $42.87 billion, a price-to-earnings ratio of 144.58, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a 50 day moving average price of $556.27 and a 200 day moving average price of $566.46.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on Axon Enterprise
Insider Activity
In other news, Director Jeri Williams sold 307 shares of the business’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 6.10% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- 3 Healthcare Dividend Stocks to Buy
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- What Investors Need to Know to Beat the Market
- AppLovin: Can Record Profits Overcome Market Skepticism?
- Why Are These Companies Considered Blue Chips?
- MarketBeat Week in Review – 04/14 – 04/18
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.